Pembrolizumab combo before/after surgery and radiation significantly improved event-free survival in resectable advanced head ...

MerckMRK reported its first-quarter 2025 results last week, beating estimates for both earnings and sales. Adjusted earnings ...

A trial by MSK researchers has shown that neoadjuvant treatment with GSK's Jemperli spared 80 percent of patients with dMMR ...